KPL-045

N/A

Report date: 2024/11/13 11:35:44

Base Information

Drug NameKPL-045
Drug Alias NameKPL-045
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionTumor necrosis factor ligand superfamily member 8 inhibitors
TargetsTumor necrosis factor ligand superfamily member 8
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNovo Nordisk Bv
China Registration ClassN/A

Develop Information

Active CompaniesNovo Nordisk Bv
Inactive CompaniesN/A
Active IndicationsAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A